Literature DB >> 25982213

Meta-analysis of surgical approaches to the treatment of parotid pleomorphic adenomas and recurrence rates.

Giuseppe Colella1, Rosangela Cannavale2, Paolo Chiodini3.   

Abstract

INTRODUCTION: Different types of surgical management of pleomorphic adenoma of the parotid gland are associated with different recurrence rates.
MATERIAL AND METHODS: A systematic review of literature until 2014 with meta-analysis was conducted. Inclusion criteria were original studies of patients with surgical management for pleomorphic adenoma of the parotid gland and recurrence rates, with a median follow-up period of 5 years. The Newcastle-Ottawa Quality Assessment Scale (NOQAS) was used to assess the quality.
RESULTS: Sixteen studies were included. Four studies show a low recurrence rate (0.01, 95% confidence interval [CI] = 0.00-0.02) after total parotidectomy. Twelve studies show a low recurrence rate (0.02, 95% CI = 0.01-0.03) after superficial parotidectomy. Six studies show a low recurrence rate (0.02, 95% CI = 0.01-0.04) after limited parotidectomy. Six studies demonstrate a low recurrence rate (0.01, 95% CI = 0.00-0.04) after extracapsular dissection. Five studies report a low-to-medium recurrence rate (0.08, 95% CI = 0.03-0.14) after extracapsular enucleation.
CONCLUSION: Information about recurrence rates, times of recurrence in relation to type of surgical treatment, and significance of capsule rupture is very poor. With regard to recurrence rates and surgical approaches, the types of operations that show the lowest recurrence rate are total parotidectomy and extracapsular dissection. Controversies over surgical treatment of PA of parotid gland remain, and the safest surgical method for the removal of this tumors has not been identified.
Copyright © 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pleomorphic adenoma; Recurrence rates; Surgical management

Mesh:

Year:  2015        PMID: 25982213     DOI: 10.1016/j.jcms.2015.03.017

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  9 in total

1.  The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.

Authors:  Laura Mc Loughlin; Sarah Louise Gillanders; Susan Smith; Orla Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-13       Impact factor: 2.503

2.  Clinicopathologic Characteristics and Prognostic Factors of Primary and Recurrent Pleomorphic Adenoma: A Single Institution Retrospective Study of 705 Cases.

Authors:  Bayan Alzumaili; Bin Xu; Maelle Saliba; Abderhman Abuhashem; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2021-11-15       Impact factor: 6.298

3.  The intact parasympathetic nerve promotes submandibular gland regeneration through ductal cell proliferation.

Authors:  Xue Wang; Zhilin Li; Qi Shao; Chunmei Zhang; Jinsong Wang; Zhengxue Han; Songlin Wang; Lizheng Qin
Journal:  Cell Prolif       Date:  2021-06-07       Impact factor: 6.831

4.  Parotid tumours: clinical and oncologic outcomes after microscope-assisted parotidectomy with intraoperative nerve monitoring.

Authors:  F Carta; N Chuchueva; C Gerosa; S Sionis; R A Caria; R Puxeddu
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

5.  Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.

Authors:  Sung Yong Choi; Jaehyuck Choi; Inwoo Hwang; Junhun Cho; Young-Hyeh Ko; Han-Sin Jeong
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

6.  Long-term Follow-up after Extracapsular Dissection of Parotid Pleomorphic Adenomas - A Retrospective Study.

Authors:  Walter Colangeli; Valerio Facchini; Aleksandr Kapitonov; Fabrizio Bozza; Roberto Becelli
Journal:  Ann Maxillofac Surg       Date:  2022-02-01

Review 7.  Patient safety and quality improvements in parotid surgery.

Authors:  Vidit Talati; Hannah J Brown; Tasher Losenegger; Peter Revenaugh; Samer Al-Khudari
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-27

8.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11

9.  Antegrade versus retrograde facial nerve dissection in benign parotid surgery: Is there a difference in postoperative outcomes? A meta-analysis.

Authors:  Mubarak Ahmed Mashrah; Taghrid Ahmed Al-Dhohrah; Fahmi Ahmed Al-Zubeiry; Lingjian Yan; Faez Saleh Al-Hamed; Xiaopeng Zhao; Chaobin Pan
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.